Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JYNARQUE safely and effectively. See full prescribing information for JYNARQUE. JYNARQUE® (tolvaptan) tablets, for oral use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).
- generic_name
- tolvaptan
- product_names
- tolvaptan
- ndc
- 59148-079, 59148-080, 59148-087, 59148-088, 59148-089, 59148-082, 59148-083, 59148-079-07, 59148-079-28, 59148-080-07, 59148-080-28, 59148-087-07, 59148-087-28, 59148-088-07, 59148-088-28, 59148-089-07, 59148-089-28, 59148-082-13, 59148-083-13
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en